Asia: Medicaments Containing Hormones Market 2025

Medicaments Containing Hormones Market Size in Asia

The Asian medicaments containing hormones market expanded markedly to $X in 2022, increasing by X% against the previous year. Overall, consumption continues to indicate a strong expansion. The level of consumption peaked at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Medicaments Containing Hormones Production in Asia

In value terms, medicaments containing hormones production rose markedly to $X in 2022 estimated in export price. Over the period under review, production enjoyed strong growth. The pace of growth appeared the most rapid in 2019 with an increase of X% against the previous year. Over the period under review, production reached the peak level at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Medicaments Containing Hormones Exports

Exports in Asia

In 2022, approx. X tons of medicaments containing hormones but not antibiotics were exported in Asia; picking up by X% on the previous year. In general, exports, however, recorded a abrupt decrease. The pace of growth was the most pronounced in 2019 when exports increased by X% against the previous year. The volume of export peaked at X tons in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

In value terms, medicaments containing hormones exports contracted slightly to $X in 2022. Over the period under review, exports, however, continue to indicate a deep reduction. The pace of growth appeared the most rapid in 2016 when exports increased by X%. Over the period under review, the exports attained the maximum at $X in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Kuwait (X tons) and Pakistan (X tons) represented the main exporters of medicaments containing hormones but not antibiotics in 2022, resulting at approx. X% and X% of total exports, respectively. It was distantly followed by Indonesia (X tons), creating a X% share of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the key exporting countries, was attained by Indonesia (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing hormones supplying countries in Asia were Kuwait ($X), Indonesia ($X) and Pakistan ($X), together accounting for X% of total exports.

Indonesia, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other leaders experienced mixed trends in the exports figures.

Export Prices by Country

In 2022, the export price in Asia amounted to $X per ton, with a decrease of X% against the previous year. Overall, the export price recorded a noticeable decline. The pace of growth was the most pronounced in 2013 an increase of X%. The level of export peaked at $X per ton in 2016; however, from 2017 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Indonesia ($X per ton), while Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kuwait (X%), while the other leaders experienced a decline in the export price figures.

Medicaments Containing Hormones Imports

Imports in Asia

In 2022, supplies from abroad of medicaments containing hormones but not antibiotics increased by X% to X tons for the first time since 2016, thus ending a five-year declining trend. Over the period under review, imports, however, continue to indicate a abrupt setback. The volume of import peaked at X tons in 2016; however, from 2017 to 2022, imports failed to regain momentum.

In value terms, medicaments containing hormones imports soared to $X in 2022. In general, imports, however, showed a deep downturn. The level of import peaked at $X in 2014; however, from 2015 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, the United Arab Emirates (X tons), distantly followed by Afghanistan (X tons), Qatar (X tons), Saudi Arabia (X tons), Oman (X tons) and Bahrain (X tons) represented the major importers of medicaments containing hormones but not antibiotics, together comprising X% of total imports. Malaysia (X tons), India (X tons), Myanmar (X tons), Pakistan (X tons), Japan (X tons) and Iraq (X tons) took a relatively small share of total imports.

From 2012 to 2022, the biggest increases were recorded for the United Arab Emirates (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, India ($X) constitutes the largest market for imported medicaments containing hormones but not antibiotics in Asia, comprising X% of total imports. The second position in the ranking was held by the United Arab Emirates ($X), with a X% share of total imports. It was followed by Japan, with a X% share.

In India, medicaments containing hormones imports increased at an average annual rate of X% over the period from 2012-2022. The remaining importing countries recorded the following average annual rates of imports growth: the United Arab Emirates (X% per year) and Japan (X% per year).

Import Prices by Country

In 2022, the import price in Asia amounted to $X per ton, jumping by X% against the previous year. In general, the import price, however, recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2014 an increase of X% against the previous year. The level of import peaked at $X per ton in 2015; however, from 2016 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was India ($X per ton), while Bahrain ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Myanmar (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :